Sign In
Buy SDGR
$15.14
-0.210 (-1.37%)
At Close: Jul 31, 2026
Kuehn Law Encourages Investors of Schrodinger, Inc. to Contact Law Firm
02:18pm, Thursday, 19'th Sep 2024
NEW YORK , Sept. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Schrodinger, Inc. (NASDAQ: SDGR) breached their
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Wednesday, 18'th Sep 2024
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported that on September 13, 2024, the company granted restricted stock units (RSUs).
2 Bill Gates stocks to turn $100 into $1,000 by 2025
07:39am, Tuesday, 03'rd Sep 2024
Bill Gates has been named the world's richest man a record 18 times. Although the billionaire has shifted his focus to philanthropic efforts as time has gone on, the Bill & Melinda Gates Foundation Tr
The 3 Best Med Tech Stocks to Buy Now
11:20am, Monday, 05'th Aug 2024
According to the Advanced Medical Technology Association, med tech is defined as “companies that develop, manufacture, and distribute the technologies, devices, equipment, diagnostic tests, and heal
Schrödinger, Inc. (SDGR) Q2 2024 Earnings Call Transcript
12:46am, Thursday, 01'st Aug 2024
Schrödinger, Inc. (NASDAQ:SDGR ) Q2 2024 Earnings Conference Call July 31, 2024 4:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations & Corporate Communications Ram
Compared to Estimates, Schrodinger (SDGR) Q2 Earnings: A Look at Key Metrics
09:05pm, Wednesday, 31'st Jul 2024
While the top- and bottom-line numbers for Schrodinger (SDGR) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compar
Schrodinger, Inc. (SDGR) Reports Q2 Loss, Tops Revenue Estimates
07:40pm, Wednesday, 31'st Jul 2024
Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.21 per share a year ago.
3 Small-Cap Stocks to Buy at a 52-Week Low
07:10am, Saturday, 27'th Jul 2024
Small-cap stocks have taken a beating in the last two years. After the meme stock craze of 2021 died down, investors found they could get more predictable thrills from large-cap technology stocks.
Earnings Preview: Schrodinger, Inc. (SDGR) Q2 Earnings Expected to Decline
11:07am, Wednesday, 24'th Jul 2024
Schrodinger (SDGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Stocks That Could Benefit Big Time From Coming Interest Rate Cuts
08:07pm, Monday, 22'nd Jul 2024
Inflation is trending downward and approaching the Federal Reserve's 2% target and unemployment is heading higher. The Fed is widely expected to begin cutting interest rates at its September meeting.
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Tuesday, 16'th Jul 2024
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported that on July 12, 2024, the company granted restricted stock units (RSUs).
3 Top-Rated Gene Editing Stocks Actually Making Money
03:11pm, Wednesday, 03'rd Jul 2024
Gene editing utilizes enzymes that cut part of the DNA strand, allowing the insertion of replacement DNA. Several approaches to gene editing have been developed, the most well-known of which is CRISPR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08:30am, Friday, 14'th Jun 2024
NEW YORK--(BUSINESS WIRE)--Schrödinger today reported that on June 11, 2024, the company granted (i) a non-statutory stock option and (ii) restricted stock units (RSUs).
Schrodinger: Buy The Drug-Discovery Platform And Get The Pipeline Nearly For Free
11:20am, Tuesday, 04'th Jun 2024
Schrödinger is a hybrid biopharma company specializing in physics-based computational chemistry and traditional drug development. The company aims to utilize computational methods to create better dr
1 Growth Stock That Could Dominate AI's Next Breakthrough
01:08pm, Saturday, 01'st Jun 2024
Highlights from analysis from 24/7 Wall Street Analysts Eric Bleeker and Austin Smith can be found below.
